Hyperthyroidism / thyrotoxicosis ⭐
hyperthyroidism · society: ATA · high-yield
Summary
The 2016 ATA guideline updates the diagnosis and management of hyperthyroidism and thyrotoxicosis, providing 124 evidence-based recommendations covering Graves’ disease (GD), toxic multinodular goiter (TMNG), toxic adenoma (TA), subclinical hyperthyroidism, pregnancy, pediatric disease, Graves’ orbitopathy (GO), thyroid storm, and amiodarone/iodine-induced thyrotoxicosis. Major changes from 2011 include new paradigms for etiology evaluation (TRAb as cost-effective first-line testing), revised antithyroid drug (ATD) management (methimazole preferred except first-trimester pregnancy), updated pregnancy guidance (switch MMI to PTU before/early in pregnancy, then consider switch back after first trimester), and expanded perioperative preparation guidance.
Current guideline: ATA 2016 Hyperthyroidism Guideline · 
download Anki sub-deck
Versions
- 2016 · ATA — ATA 2016 Hyperthyroidism Guideline